Skip to content

Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement

FY'25FY'24FY'23
$31.58M+3.8%$30.43M+14.6%$26.57M
$187.55M+156%$73.14M+4.2%$70.18M
$49.11M$7.82M
$75.15M+219%$23.55M+1,003%$2.14M
$267.91M+102%$132.92M+28.3%$103.62M
$8.6M+80.1%$4.78M+92.9%$2.48M
$328.74M+120%$149.65M+36.0%$110.04M
$16.34M+269%$4.43M+160%$1.7M
$3.3M+77.3%$1.86M+629%$255K
$30.92M+46.2%$21.15M+99.4%$10.61M
$41.13M-44.1%$73.63M+43.2%$51.43M
$4K+300%$1K
-$369.94M-24.7%-$296.74M-29.2%-$229.66M
$287.61M+217%-$245.36M-20.8%-$203.11M-19.4%
$328.74M+120%$149.65M+36.0%$110.04M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Beta Bionics, Inc. Common Stock's total assets?
Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
How much debt does Beta Bionics, Inc. Common Stock have?
Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Beta Bionics, Inc. Common Stock have?
Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
Its current ratio is 10.69 — current assets exceed current liabilities.
Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.